ReviewCancer treatment reviews2016

Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.

Worapol Ngamcherdtrakul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.